“Tirzepatide: Dual GIP GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”. InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes 1, no. 2 (September 3, 2024): 96–110. Accessed August 3, 2025. https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12.